From the monthly archives:
SAN DIEGO–(BUSINESS WIRE)–June 26, 2006–Imagenetix, Inc. (OTCBB:IAGX – News) today announced it has engaged the services of Michael Hamrell, Ph.D., president of MORIAH Consultants, a regulatory affairs and clinical research consulting firm near Los Angeles. Dr. Hamrell, who has held leading positions within the FDA and NIH and served as a regulatory affairs and pharmaceutical [...]
{ Comments on this entry are closed }
SAN DIEGO–(BUSINESS WIRE)–June 1, 2006–Imagenetix Inc. (OTCBB: IAGX – News) today announced that its proprietary anti-inflammatory compound, 1-tetradecanol complex (1-TDC), intended for use in the treatment of periodontal disease and other widespread inflammatory conditions, has achieved expected results in important baseline acute toxicity studies. In the first study, CD-1 mice were administered 1-TDC orally at [...]
{ Comments on this entry are closed }